WallStreetZenWallStreetZen

NASDAQ: NEUP
Neuphoria Therapeutics Inc Stock Ownership - Who owns Neuphoria Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neuphoria Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lynx1 Capital Management LP10% Owner2025-10-21639,110$5.14
$3.28MBuy

1 of 1

NEUP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NEUP insiders and whales buy or sell their stock.

NEUP Shareholders

What type of owners hold Neuphoria Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Spyros Papapetropoulos111.02%5,999,940$23.52MInsider
Lynx1 Capital Management LP16.20%875,328$3.43MInstitution
Peter Miles Winston Davies5.00%269,984$1.06MInsider
David Ian Wilson4.66%251,939$987.60kInsider
Lynx1 Capital Management LP4.37%236,218$925.97kInsider
Advisorshares Investments LLC2.87%155,367$609.04kInstitution
Shay Capital LLC2.79%151,010$591.96kInstitution
Balyasny Asset Management LP2.63%142,183$557.36kInstitution
Alan Fisher1.85%100,000$392.00kInsider
Vanguard Capital Management LLC1.82%98,516$386.18kInstitution

1 of 3

NEUP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NEUP20.40%79.60%Net Buying
ELOX0.00%100.00%Net Buying
CLRB3.89%42.22%Net BuyingNet Buying
QCLS7.51%92.49%Net Buying
LGVN7.32%61.23%Net SellingNet Selling
View Top Biotech Stocks

Neuphoria Therapeutics Stock Ownership FAQ

Who owns Neuphoria Therapeutics?

Neuphoria Therapeutics (NASDAQ: NEUP) is owned by 32.53% institutional shareholders, 126.89% Neuphoria Therapeutics insiders, and 0.00% retail investors. Spyros Papapetropoulos is the largest individual Neuphoria Therapeutics shareholder, owning 6.00M shares representing 111.02% of the company. Spyros Papapetropoulos's Neuphoria Therapeutics shares are currently valued at $23.28M.

If you're new to stock investing, here's how to buy Neuphoria Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.